Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-25-001115
Filing Date
2025-01-14
Accepted
2025-01-14 16:17:38
Documents
2
Period of Report
2025-01-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1421
2 lkellypoa.htm EX-24 11168
  Complete submission text file 0001437749-25-001115.txt   14469
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Issuer) CIK: 0000946486 (see all company filings)

EIN.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O VALLON PHARAMCEUTICALS, INC. 100 N 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address
Kelly Leanne (Reporting) CIK: 0001398278 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39290 | Film No.: 25529569